- Home
- HLXB vs LUNG Comparison
HLXB vs LUNG Comparison
Compare HLXB & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLXB
- LUNG
- Stock Information
- Founded
- HLXB 2021
- LUNG 1995
- Country
- HLXB United States
- LUNG United States
- Employees
- HLXB N/A
- LUNG N/A
- Industry
- HLXB
- LUNG Industrial Specialties
- Sector
- HLXB
- LUNG Health Care
- Exchange
- HLXB NYSE
- LUNG Nasdaq
- Market Cap
- HLXB 245.7M
- LUNG 251.5M
- IPO Year
- HLXB 2024
- LUNG 2020
- Fundamental
- Price
- HLXB $10.80
- LUNG $6.23
- Analyst Decision
- HLXB
- LUNG Buy
- Analyst Count
- HLXB 0
- LUNG 6
- Target Price
- HLXB N/A
- LUNG $11.92
- AVG Volume (30 Days)
- HLXB 12.4K
- LUNG 242.6K
- Earning Date
- HLXB 01-01-0001
- LUNG 02-19-2025
- Dividend Yield
- HLXB N/A
- LUNG N/A
- EPS Growth
- HLXB N/A
- LUNG N/A
- EPS
- HLXB N/A
- LUNG N/A
- Revenue
- HLXB N/A
- LUNG $79,302,000.00
- Revenue This Year
- HLXB N/A
- LUNG $22.26
- Revenue Next Year
- HLXB N/A
- LUNG $18.72
- P/E Ratio
- HLXB N/A
- LUNG N/A
- Revenue Growth
- HLXB N/A
- LUNG 22.34
- 52 Week Low
- HLXB $10.03
- LUNG $5.46
- 52 Week High
- HLXB $10.99
- LUNG $14.84
- Technical
- Relative Strength Index (RSI)
- HLXB N/A
- LUNG 41.37
- Support Level
- HLXB N/A
- LUNG $5.72
- Resistance Level
- HLXB N/A
- LUNG $6.28
- Average True Range (ATR)
- HLXB 0.00
- LUNG 0.40
- MACD
- HLXB 0.00
- LUNG -0.03
- Stochastic Oscillator
- HLXB 0.00
- LUNG 19.85
About HLXB HELIX ACQUISITION CORP. II
Helix Acquisition Corp II is a Blank check company.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.